The FDA has approved Moderna's new mRNA flu vaccine for adults ages 50 years and older. Moderna expects the vaccine to be available in the United States for the 2026 to 2027 flu season.
<ul><li>The Food and Drug Administration (FDA) has approved Modernas mFLUSIVA, the first mRNA-based flu vaccine, for adults ages 50 and older.</li><li>mRNA flu vaccines can be produced more quickly t… [+6809 chars]